Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 9/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.47 |
| ▸ | DHODH | Q02127 | 2/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 8/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.40 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24252784 | 0.91 | CYP11B1 (0.62) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL19638272 | 0.86 | CYP11B1 (0.66) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL21725403 | 0.86 | CYP11B1 (0.66) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL19638082 | 0.85 | CYP11B1 (0.64) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL24252568 | 0.85 | DHODH (0.53) | CYP11B1CYP19A1DHODHCYP11B2KDM4E | |
| SCHEMBL22227765 | 0.84 | CYP11B1 (0.67) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL24252242 | 0.82 | CYP11B1 (0.68) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL17918052 | 0.82 | CYP11B1 (0.68) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL24252593 | 0.82 | CYP11B1 (0.68) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL30857455 | 0.82 | CYP11B1 (0.68) | CYP11B1CYP19A1DHODHGPR84CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220052268-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO., LTD. (JP) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220052268-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLC29A1, NUDT1, SLC29A2 | CYP11B1 4052/4885CYP19A1 2810/4885DHODH 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.